Atypical presentation of cerebral schistosomiasis four years after exposure to Schistosoma mansoni  by Rose, Matthew F. et al.
Epilepsy & Behavior Case Reports 2 (2014) 80–85
Contents lists available at ScienceDirect
Epilepsy & Behavior Case Reports
j ourna l homepage: www.e lsev ie r .com/ locate /ebcrCase ReportAtypical presentation of cerebral schistosomiasis four years after
exposure to Schistosoma mansoni☆Matthew F. Rose a,⁎,1, Eli E. Zimmerman b,1, Liangge Hsu c, Alexandra J. Golby c,d, Emam Saleh d,
Rebecca D. Folkerth a, Sandro S. Santagata a, Danny A. Milner Jr. a, Shakti H. Ramkissoon a
a Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, USA
b Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, USA
c Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, USA
d Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, USA☆ This is an open-access article distributed under the t
Attribution-NonCommercial-No Derivative Works L
commercial use, distribution, and reproduction in any me
thor and source are credited.
⁎ Corresponding author at: Department of Pathology, B
75 Francis Street, Boston, MA 02115, USA.
E-mail addresses:mfrose@bics.bwh.harvard.edu (M.F.
sramkissoon@partners.org (S.H. Ramkissoon).
1 These authors contributed equally to this work.
2213-3232/$ – see frontmatter© 2014 TheAuthors. Publi
http://dx.doi.org/10.1016/j.ebcr.2014.01.006a b s t r a c ta r t i c l e i n f oAvailable online 12 February 2014Keywords:
Cerebral schistosomiasis
Neuroschistosomiasis
Schistosoma mansoni
Generalized tonic–clonic seizure
GranulomaSchistosomiasis is the second most socioeconomically devastating parasitic disease worldwide, affecting over
240 million people in 77 countries on 5 continents and killing 300,000 people annually in sub-Saharan Africa
alone. Neuroschistosomiasis is caused by granuloma formation around eggs that lodge in the CNS, with
Schistosoma mansoni and Schistosoma haematobium usually affecting the spinal cord and Schistosoma japonicum
causing most reported cerebral disease. We report a case of a previously healthy 25-year-old woman native to
the United States who presented with a single generalized tonic–clonic seizure without other neurologic symp-
toms four years after spending a semester in Ghanawhere shewent swimming once in a river. BrainMRI showed
areas of signal abnormality andmottled nodular linear enhancement in the left temporal and right posterior tem-
poral/parietal lobes and right cerebellumwithoutmass effect. A biopsy of the left temporal lesion showed prom-
inent granulomas with dense mixed inﬂammatory inﬁltrates composed of eosinophils, plasma cells, and
lymphocytes surrounding refractile egg shells containing characteristic embryonal cells and von Lichtenberg's
envelope and displaying the pathognomonic spine shape of S. mansoni. Serum ELISA and antibody immunoblots
conﬁrmed exposure to S. mansoni. In summary, we describe the atypical combination of cerebral schistosomiasis
due to S. mansoni, after a prolonged interval of four years, from a single known exposure.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Schistosomiasis has afﬂicted humans for thousands of years and is
now the second most socioeconomically devastating parasitic disease
worldwide, affecting over 240 million people in 77 countries on 5 con-
tinents and killing an estimated 300,000 people annually in sub-
Saharan Africa alone [1,2]. Nearly 800 million people are currently at
risk of developing schistosomiasis worldwide [1]. The three main spe-
cies of Schistosoma (digenetic blood trematode ﬂatworms) infecting
humans are Schistosoma haematobium, Schistosoma mansoni, anderms of the Creative Commons
icense, which permits non-
dium, provided the original au-
righam and Women's Hospital,
Rose),
shed byElsevier Inc. This is anopenaccSchistosoma japonicum. Schistosoma mansoni and S. haematobium are
endemic acrossmuch of Africa and theMiddle East, often in overlapping
geographic distributions. S. mansoni is also prevalent in areas of South
America and the Caribbean. In contrast, S. japonicum is primarily
found in the Far East. Two other species, Schistosoma mekongi and
Schistosoma intercalatum, are more geographically restricted with
S. mekongi found very focally in Southeast Asia and S. intercalatum
found mainly in central West Africa [3,4].
Infection by schistosomes requires contact with freshwater where
mobile larval forms emerge from intermediate host snails and penetrate
the skin, sometimes provoking an urticarial rash lasting several days.
Adult worms migrate to the venous plexuses of speciﬁc host tissues,
where they form mating pairs and copulate throughout their 3- to 5-
year lifespan, laying eggs to be eliminated in either feces or urine
(Fig. 1). The different species of Schistosoma show some correlation
with speciﬁc tissue types, which in turn correspond to the mode of
egg elimination. Schistosoma japonicum and S. mansoni showpreference
for the mesenteric venules of the bowel/rectum, while S. haematobium
shows preference for the venous plexus of the bladder [5–7].
Much of the pathology of schistosomiasis results from inﬂammatory
reactions to the eggs and resulting damage of the surrounding organs.essarticleunder theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Schistosome life cycle. The stages of the schistosome life cycle (1–10) include (1) elimination from the host as eggs in feces or urine (diagnostic stage), (2) hatching of miracidia,
(3) infection of species-speciﬁc aqueous snail intermediate hosts, (4) proliferation of sporocysts within snails, (5) release of cercariae into water (infective stage), (6) infection of host by
skin penetration, (7) development into schistosomulae, (8) circulation, (9)maturationwithin portal vasculature, and (10)migration of paired adultworms to target organs. Elimination of
schistosome eggs in either feces or urine depends onwhether the adults reside in the mesenteric venules of the bowel/rectum (primarily (A) Schistosoma japonicum and (B) Schistosoma
mansoni) or in the venous plexus of the bladder (primarily (C) Schistosoma haematobium), respectively.
Figure provided by A. J. da Silva and M. Moser for copyright-free dissemination through the Public Health Image Library of the Centers for Disease Control and Prevention [7].
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to some correlations between speciﬁc species and the incidence of par-
ticular organ injury. For instance, the pathology of S. mansoni and
S. japonicum includes hepatic perisinusoidal egg granulomas/Symmers'
pipe stem periportal ﬁbrosis, portal hypertension, as well as Katayama
fever. In contrast, the pathology of S. haematobium revolves around
the urinary tract with frequent hematuria, bladder/lower ureter scar-
ring, and calciﬁcation with resulting renal parenchymal damage and
kidney failure as well as an association with squamous cell carcinoma
of the bladder [3,5,8]. All three Schistosoma species can also affect the
central nervous system as neuroschistosomiasis [4,9].
Neuroschistosomiasis resultswhen eggs, instead of being eliminated
in feces or urine, spread to the central nervous system and induce the
formation of granulomas. Involvement of the brain (cerebral/encephalic
schistosomiasis or cerebral granulomatous disease) often leads to sei-
zures, whereas involvement of the spinal cord (spinal cord schistosomi-
asis or schistosomal myeloradiculopathy) can cause cord compression
resulting in paralysis. Similar to the organ distribution described
above, different Schistosoma species have prevalence for affecting either
the brain or spinal cord. Schistosoma japonicum primarily involves the
brain, while S. mansoni and S. haematobium primarily affect the spinal
cord. However, occasional cases of cerebral schistosomiasis due to
S. mansoni continue to be reported, and it is possible that its frequency
of cerebral involvement may be underreported [10–13]. In areas
where S. haematobium is endemic, spinal schistosomiasis is the leading
cause of spinal cord damage. Involvement of the CNS is thought to be
most frequently due to embolization of eggs, but some cases of adult
schistosomes traveling to the CNS vasculature have been reported.
Symptoms can present soon after infection in the case of acute
schistosomal encephalopathy, but delayed reactions for months and
sometimes for years have been reported in cerebral schistosomiasis
[3,4,9].2. Case presentation
The patient is a previously healthy 25-year-old female native of
Massachusetts, U.S., who presented to the Brigham and Women's Hos-
pital emergency department after the ﬁrst seizure in her life. She had
been feeling fatigued on the train that morning, and her symptoms
worsened over the day. A coworker had her sit down, at which point
she had difﬁculty answering questions. She then fell off a chair and had
a witnessed generalized tonic–clonic seizure, which lasted for 3 min
(without incontinence), followed by 30min of more pronounced fatigue
and confusion. In the emergency department, she was fully alert and ori-
ented, followed all commands without difﬁculty, and had ﬂuent speech.
Concentration, attention, and memory were intact, as was her ability to
read, name, and analyze a picture. The remainder of her neurologic
exam was normal. A CT scan at that time also showed no abnormalities.
Her past medical history is notable only for headaches and eczema.
Her headaches, which began in childhood, are infrequent and occur
only once or twice per year. They are usually preceded by a scintillating
scotoma and often resolve without medications. She also had a tick bite
prior to her current course, though she had no subsequent rash and had
a negative Lyme titer. In her family, she has a maternal uncle with epi-
lepsy (unknown type), a maternal aunt with migraines, and a mother
with cardiac arrhythmias. She is a vegetarian and does not smoke,
drink, or use illicit drugs. She is HIV-negative. She has traveled to En-
gland twice and lived in Ghana for one semester of college, four years
prior to the onset of symptoms. During that trip, she lived mainly in
the university town of Legon, 12 km northeast of the capital city of
Accra, and she reported swimming once during the trip in a freshwater
river that runs parallel to the ocean, east of the capital city. She did not
recall swimming in any lakes. She recalled no particular symptoms dur-
ing her stay, apart from one episode of dysuria that lasted less than a
day. In the last 4 years, she has been perfectly well until this episode.
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experienced an episode of altered consciousness (possibly a partial sei-
zure) prior to the 4th visit. Peripheral blood showed no abnormal ﬁnd-
ings: WBC: 9.3, HGB: 12.9, HCT: 39.8, PLT: 226 (POLY: 58, BAND: 0,
LYMPH: 31, MONO: 7, EOS: 2, and BASO: 0). Likewise, serum chemis-
tries were within normal ranges: glucose: 91, BUN: 6, creatinine: 0.64,
sodium: 140, potassium: 3.8, chloride: 100, total CO2: 26, alkaline phos-
phatase: 54, ALT: 11, AST: 17, total bilirubin: 0.2, total protein: 7.5,
albumin: 4.6, calcium: 9.4, and magnesium: 1.9.
A lumbar puncture was performed, and CSF showed no abnormal
ﬁndings: glucose: 55, protein: 19, WBC: 2 (91% lymphocytes), and
RBC: 0. Likewise, rheumatologic labs were within normal ranges: CRP:
0.6, MPO: 0, PR3: 4, and ANA and ANCA: negative. She was started on
the antiepileptic drug levetiracetam to prevent further seizures.
Electroencephalography (EEG) showed good organization at rest,
but occasional abnormal left temporal theta slowing was noted, maxi-
mal at T3. There were no deﬁnite epileptiform abnormalities (Fig. 2).
These ﬁndings are suggestive of mild left temporal dysfunction.
Brain MRI imaging showed areas of abnormal T2 and FLAIR signal at
the medial and lateral aspects of the anterior left temporal and right
posterior temporal parietal lobes (with the left more affected than the
right), aswell as a similar small area of abnormality of the right cerebel-
lum (Figs. 3A–C). After contrast administration, all these areas showed
mottled nodular linear enhancement without signiﬁcant mass effect
(Figs. 3D–F). No associated diffusion abnormality or mineralization or
hemorrhagewas seen. Likewise, therewas no asymmetric hippocampal
volume loss or gray matter heterotopia, and ventricles were normal in
size. Possible etiologies of these imaging ﬁndings could include a spec-
trum of vasculitides, lymphomatoid granulomatosis, infection, and,
less likely, granulomatous disease or tumor.
Additional functional MRI (fMRI) brain mapping was performed
for presurgical planning and showed ﬁndings consistent with left-
sided language lateralization but also showed the functional languageFig. 2. Electroencephalography shows left temporal dysfunction. This electroencephalogram (E
drowsy, and sleeping states, is abnormal because of occasional left temporal theta slowing. The
tiform abnormalities.regions to be apart from the areas of left temporal lobe signal abnormal-
ity. An image-guided left temporal craniotomy for open biopsy of the
area of signal abnormality was performed. Upon inspection, the surface
of the brain was abnormal with some speckled appearance and some in-
creased vascularity. A 0.5-cm biopsy was taken from the anterior/
inferior left temporal lobe and appeared grossly abnormal with areas of
possible necrosis. In addition, tissue was sent for microbiologic cultures.
Initial intraoperative consultationwith frozen section/smear evalua-
tion showed collections of histiocytes concerning for granulomas, vas-
cular involvement, and necrosis suspicious for an infectious process
(Figs. 4A–B). Subsequent evaluation of parafﬁn-embedded permanent
sections showed brain tissue with extensive granuloma formation and
dense mixed inﬂammatory inﬁltrates comprised of eosinophils, plasma
cells, histiocytes, and lymphocytes (Figs. 5A–B). Review of multiple tis-
sue sections revealed refractile shell fragments at the center of each
granuloma with occasional intact shells showing the pathognomonic
acentric spine shape of S. mansoni (Fig. 6A) [14].
Serum ELISA and antibody immunoblots performed at the Center for
Disease Control and Prevention (CDC) conﬁrmed exposure to S. mansoni
and showed lack of exposure to S. haematobium, the othermost prevalent
schistosome species in Ghana. The S. mansoni AB FAST-ELISA produced a
score of 100 (positive score considered >10; 99% sensitivity for
S. mansoni; 90% sensitivity for S. haematobium; 95% speciﬁcity for schisto-
somal infection). The S. mansoni AB immunoblot was positive, while the
S. haematobium AB immunoblot was negative. Hence, the patient was
diagnosed with cerebral schistosomiasis (neuroschistosomiasis) due to
S. mansoni. Stool and urine were repeatedly negative for ova.
The patient was started on dexamethasone to control inﬂammation
and received praziquantel (2 doses) immediately after the histologic di-
agnosis in order to kill any remaining adult schistosomes. The steroids
were tapered over one month, at which point she received another
course of praziquantel (2 doses). She was maintained on levetiracetam
for seizures. She has had no additional symptoms in the subsequentEG), performed with anterior temporal and standard 10–20 electrodes during the waking,
se ﬁndings are suggestive of mild left temporal dysfunction. There are no deﬁnite epilep-
A B
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Fig. 3. Lesions in the temporal/parietal cortex and cerebellum show nodular enhancement and edema. Axial T2 (A) and FLAIR (B, C) MRI images show increased signal at the right cere-
bellum (A, arrows) and right parietal (B, arrows) and left temporal (C, arrows) lobes consistent with edema. Axial post-gadolinium contrast images show corresponding clusters of small
(1–3 mm) enhancing nodules at the right cerebellum (D, arrows) and right parietal (E, arrows) and left temporal (F, arrows) lobes. These ﬁndings likely represent granulomatous tissue
surrounding the eggs. The differential diagnosis based on these radiologicﬁndingswould include a spectrumof vasculitides, lymphomatoid granulomatosis, infection, and, less likely, gran-
ulomatous disease or tumor.
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and stools continue to be negative for ova.
3. Discussion
Cerebral (encephalic) schistosomiasis was ﬁrst described by
Yamagiwa, a student of Rudolf Virchow, in 1889 [15]. It ismost often as-
sociated with S. japonicum infection in East Asia, where that species is
most prevalent, and has only occasionally been reported to be caused
by S. mansoni or S. haematobium. In contrast, both S. mansoni and
S. haematobium, but not S. japonicum, are endemic to Ghana, the likely
source of infection for the current case [3]. Hence, this presentation of
cerebral schistosomiasis due to S. mansoni four years after a single
known exposure is an atypical presentation.A
Fig. 4. Tissue smear and frozen section reveal extensive inﬂammatory inﬁltrates and necrosis in
with perivascular inﬂammation (black arrows) and areas of necrosis. (B) Frozen section of left t
histiocyte clusters) and scattered eosinophils concerning for granulomas (yellow arrows). Path
and lymphomatoid granulomatosis.Cerebral schistosomiasis can presentwith variable clinical and imag-
ing characteristics that can overlap with that of epilepsy, brain tumors,
vasculitis, stroke, granulomatous disease, and other disorders [4]. Pa-
tients can present with a combination of partial or generalized tonic–
clonic seizures, increased intracranial pressure, focal neurological deﬁ-
cits, and headache [16]. Electroencephalogram can help localize the dis-
ease in some cases but can also be normal in some patients [4,17].
The lesions of neuroschistosomiasis can occur in both the cerebral
hemispheres and cerebellum/brain stem. On postcontrast MRI, the le-
sions can appear as a large mass comprisingmultiple intensely enhanc-
ing nodules or as a central linear enhancement surrounded by multiple
enhancing punctate nodules sometimes appearing “arborized.” Occa-
sionally, they have also been reported to appear as nonenhancing irreg-
ular “ﬁnger-like” areas of abnormal signal consistent with increasedB
the temporal cortex. (A) Smear preparation of left temporal cortex biopsy showing vessels
emporal cortex biopsy showing prominent collections of mononuclear cells (macrophage/
ologic differential of this appearance includes infection (TB vs. schistosomiasis), vasculitis,
A B
Fig. 5.Extensive granulomas are present in the temporal cortex. (A)Aparafﬁn section of the formalin-ﬁxed temporal lobe biopsy shows reactive brain tissue extensively involvedby prom-
inent granuloma formation and reactive gliosis. (B) A magniﬁed view of one granuloma pictured in the yellow box in (A) shows dense mixed inﬂammatory inﬁltrates comprised of eo-
sinophils, plasma cells, and lymphocytes.
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tosomiasis due to S. mansoni, as in the current case, are not well de-
scribed because of its comparable rarity. In the current case as well as
in three other reported cases of cerebral schistosomiasis due to
S. mansoni, the imaging does appear to show a similar pattern of en-
hancing punctate nodules clustered irregularly around some linear en-
hancement, with surrounding edema. Thus, this imaging pattern mayA
R
L
M
Fig. 6. An infectious etiology: Schistosomamansoni. (A) Magniﬁcation of the center of one of
the granulomas reveals an egg with a refractile shell showing the pathognomonic acentric
spine shape of Schistosoma mansoni. Reynolds' layer (R) has ﬁlled the spine but is not well
deﬁned with regard to the remaining egg shell. A single layer of squamous cells (von
Lichtenberg's envelope) (L) is seen at the apex of the egg and is closely adherent to Reynold's
layer. The envelope surrounds the developing miracidium (M) with multiple nuclei [14].
Neutrophils and histiocytes adjacent to the egg highlight the smaller size of the schistosome
nuclei in comparison to those in human cells. (The image is taken at 40×without a condens-
er in order to increase refraction and highlight the contour of the egg shell. Bar = 10 μm.).be generally applicable to cerebral schistosomiasis due to both
S. mansoni and S. japonicum [10,11].
Direct pathologic evaluation of the involved tissue, as in the current
case, is still the gold standard for diagnosis. Observation of the spine
placement on the egg shell (lateral for S. mansoni, midline for
S. haematobium, and absent for S. japonicum) is pathognomonic for
each species. However, a combination of the serum indirect hemagglu-
tination (IHA) test and enzyme-linked immunosorbent assay (ELISA)
shows high sensitivity and speciﬁcity for S. mansoni, and both are
often used in addition to histologic evaluation to conﬁrm the species di-
agnosis, especially if intact eggs are not identiﬁed on histologic sec-
tions [16,21]. Other tests such as evaluation of stool and urine for ova
can be very useful if positive but are often negative. Overall, as in our
case, a combination of these diagnostic approaches is required [4].
Schistosomiasis pathology is driven by host inﬂammatory response
to the eggs and hence correlates with where the eggs are deposited.
Schistosomamansoni and S. japonicum can cause Katayama fever, hepat-
ic perisinusoidal egg granulomas, and periportal ﬁbrosis and portal hy-
pertension, whereas S. haematobium is more frequently associated with
hematuria and bladder wall scarring [3,5]. Moreover, speciﬁc schisto-
some species are associated with the development of speciﬁc cancers,
such as the correlation between S. haematobium infection and the de-
velopment of squamous cell carcinoma of the bladder. In areas where
S. haematobium is endemic, squamous cell carcinoma of the bladder is
the leading form of cancer in the population. Other studies have like-
wise suggested links between S. japonicum and hepatocellular carcino-
ma and between S. mansoni and colorectal adenocarcinoma, although
more evidence is needed [8].
Treatment of schistosomiasis consists of antischistosomal therapy (i.e.,
praziquantel) plus corticosteroids to control the inﬂammation [22]. Some
cases involving the posterior fossa with resultingmass effect may also re-
quire treatment with surgical resection [20]. While the current patient
showed involvement of both the cerebral cortex and cerebellum, there
was no signiﬁcant mass effect, and the patient was treated successfully
withmedical therapy after the diagnostic biopsy. Anticonvulsants are fre-
quently needed for a period of time, but studies suggest that long-term
antiepileptic therapy is not required in most cases of cerebral schistoso-
miasis [17]. Unfortunately, neuroschistosomiasis can sometimes result
in signiﬁcant postexposure chronic sequelae includingmedically refracto-
ry epilepsy that may require surgical treatment in the case of cerebral
schistosomiasis and paralysis in the case of spinal cord schistosomiasis
[4,23]. Theworst outcomes have been seen in spinal cord schistosomiasis
where some studies have reported that only 15% of treated patients expe-
rience a complete recovery, while other studies have shown that early
aggressive treatment can lead to full recovery in up to 65% of patients
[4,24].
85M.F. Rose et al. / Epilepsy & Behavior Case Reports 2 (2014) 80–85Of note, other schistosome species are found indigenously in the U.S.
but die after penetrating human skin, giving rise to a similar initial aller-
gic condition called “swimmer's itch”, or cercarial dermatitis, but not
progressing to the other manifestations of the disease. The primary
hosts for these other species are instead water fowl (Austrobilharzia
variglandis, Microbilharzia sp., Trichobilharzia ocellata, Trichobilharzia
physella, Trichobilharzia stagnicolae) and rodents (Schistosomatium
douthitti) [25]. Because the speciﬁc snail species required as intermedi-
ate hosts for S. japonicum, S. mansoni, and S. haematobium are not pres-
ent in the United States, the transmission of these organisms in the
United States waterways is currently unlikely [25].
4. Conclusions
In summary, we describe the atypical combination of cerebral schis-
tosomiasis due to S. mansoni, after a prolonged four-year interval, from
apparently a single exposure. The imaging characteristics of irregular
nodular enhancement seen in this case mirror those reported in the
much more frequent cerebral schistosomiasis due to S. japonicum and
support previous suggestions that these imaging ﬁndings are applicable
to cerebral schistosomiasis caused by both species. The clinical manifes-
tations of cerebral schistosomiasis are variable and can overlap with
that of epilepsy, brain tumors, vasculitis, and stroke. Hence, a combina-
tion of history, imaging data, laboratory ﬁndings, and pathologic analy-
sis is critical for diagnosis.
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